
This content was machine translated.
About Mermaid Bio
Today’s antibody drugs reach only 10% of their potential targets, leaving many patients without treatment options. Mermaid Bio is pioneering the development of intrabody therapies to give patients new hope. Using cutting-edge biotechnology, the company develops antibodies for intracellular targets (intrabodies) and treats diseases from within. Mermaid Bio is developing the next generation of antibody drugs to treat currently untreated patients in the future.
More like this
Discover more articles, startups, and events from the ecosystem

Ecosystem
NextGen Takeover: How We Are Setting the Course for Tomorrow’s Entrepreneurs
06.08.26
4 Min.

Inside Stories
Upcoming Startups in July
06.08.26
3 Min.

Ecosystem
Munich Startup 2.0: From Showcase to Orientation Platform
05.08.26
4 Min.

Networking
Monthly Meetup: Erfinder Verein / Inventors Association
August 11, 2026
07:00 PM – 10:30 PM
Ristorante Firenze, Munich

Workshop
How to Turn Your Communication into a Strategic Asset
September 15, 2026
10:00 AM – 11:30 AM
gate – Garchinger Technologie- und Gründerzentrum GmbH, Garching bei München


